IGF2 and breast cancer: Since LOI resulted in higher intratumoral free IGF-II, we can expect, then, that LOI will contribute to an enhanced proliferative cell signaling milieu promoting a fast growing tumor, chemoresistance, and increased breast cancer death [17].